Doç. Dr.Özgür Harmancı

  • İlgi Alanları
  • Mide hastalıkları
  • İnflamatuar barsak hastalığı
  • Çölyak hastalığı
  • Kolon polipleri
  • Hassas barsak sendromu
  • Kabızlık
  • Karaciğer hastalıkları
  • Safra kesesi hastalıkları

Eğitim ve Uzmanlık
1999 - İstanbul Üniversitesi Cerrahpaşa İngilizce Tıp Fakültesi
2004 - Hacettepe Üniversitesi İç Hastalıkları Uzmanlığı
2008 - Hacettepe Üniversitesi Gastroenteroloji Uzmanlığı

Deneyim
2016 - 2021 - Özel Koru Hastanesi Gastroenteroloji Kliniği
2016 - 2016 - Gastroenteroloji Doçenti
2012 - 2015 - Başkent Üniversitesi Gastroenteroloji BD (Yardımcı Doçent)
2010 - 2012  –  Hacettepe Üniversitesi Gastroenteroloji BD
2008 - 2010 - Şanlıurfa EAH (Devlet Hizmet Yükümlülüğü)
2007 - Hacettepe Üniversitesi görevlendirmesi ile ABD-Wayne State Üniversitesi Gastroenteroloji Kliniği
2002 - 2003 - Hacettepe Üniversitesi İç Hastalıkları AD, Başasistan
1999 - 2004 - Hacettepe Üniversitesi İç Hastalıkları AD

Kurs ve Sertifikalar
2011 - Hayvan Deneyleri Sertifikası (Hacettepe Üniversitesi)
2011 - Eğiticilerin Eğitimi Sertifikası (Hacettepe Üniversitesi)

Mesleki Üyelikler
Türk Gastroenteroloji Derneği
Türk Karaciğer Araştırmaları Derneği
Türk İnflamatuar Barsak Hastalıkları Derneği

Uluslararası hakemli dergilerde yayımlanan makaleler


A1. Öcal S, Korkmaz M, Harmancı Ö, et al. Hepatitis B- and hepatitis D-virus-related liver transplant: single-center data. Exp Clin Transplant. 2015;13 Suppl 1:133-138.

A2. Öcal S, Harmancı Ö, Korkmaz M, et al. Panel reactive antibodies in predicting hepatitis C virus treatment outcome in kidney transplant candidates. Exp Clin Transplant. 2015;13 Suppl 1:193-196.

A3. Öcal S, Harmancı Ö, Ensaroğlu F, et al. Endoscopic Retrograde Cholangiopancreatography in Kidney Transplant Patients: Results From a Single Center. Exp Clin Transplant. 2015;13 Suppl 3:93-96.

A4. Korkmaz M, Fakı S, Öcal S, Harmancı Ö, Selçuk H, Haberal M. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection. Exp Clin Transplant. 2015;13 Suppl 1:159-164.

A5. Korkmaz M, Fakı S, Öcal S, Harmancı Ö, Ensaroğlu F, Selçuk H, Haberal M.. The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients. Exp Clin Transplant. 2015;13 Suppl 1:188-192.

A6. Harmancı Ö, İlin S, Öcal S, et al. The Effect of Hepatitis B Virus on Graft and Overall Survival in Kidney Transplant Patients. Exp Clin Transplant. 2015;13 Suppl 3:36-40.

A7. Harmancı Ö, Ensaroğlu F, Özçay F, et al. Late-Onset Drug-Induced Cholestasis in a Living-Related Liver Transplant Donor With Progressive Familial Intrahepatic Cholestasis. Exp Clin Transplant. 2015;13 Suppl 3:107-109.

A8. Ensaroğlu F, Harmancı Ö, Öcal S, et al. Significance of Colonoscopic Findings in Patients After Kidney Graft. Exp Clin Transplant. 2015;13 Suppl 3:55-57.

A9. Harmancı Ö, Selçuk H, Haberal M. Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New? J Clin Transl Hepatol. 2014;2(4):259-265.

A10. Harmancı Ö, Kav T, Sökmensüer C, Çalgünerı M, Bayraktar Y. Successful management of severe acute liver disease related with adult-onset Still's disease in a pregnant patient. Turk J Gastroenterol. 2013;24(1):61-64.

A11. Harmanci O, Kav T, Peynircioglu B, et al. Long-term follow-up study in Budd-Chiari syndrome: single-center experience in 22 years. J Clin Gastroenterol. 2013;47(8):706-712.

A12. Kav T, Harmanci O, Ozseker B. Buried haemoclips: how long do they remain. J Gastrointestin Liver Dis. 2012;21(3):327-328.

A13. Harmanci O, Kav T, Sivri B. Red cell distribution width can predict intestinal atrophy in selected patients with celiac disease. J Clin Lab Anal. 2012;26(6):497-502.

A14. Harmanci O, Bayraktar Y. How can portal vein cavernous transformation cause chronic incomplete biliary obstruction? World J Gastroenterol. 2012;18(26):3375-3378.

A15. Efe C, Ozseker B, Kav T, Harmanci O, Bayraktar Y. Intramural hematoma of the esophagus as a complication of anticoagulant or antiplatelet therapy. Scand J Gastroenterol. 2011;46(11):1399-1400.

A16. Duman AE, Ersoy O, Abbasoglu O, et al. Misdiagnosis of gossypiboma as hydatid cyst. Indian J Gastroenterol. 2011;30(6):285.

A17. Bayraktar Y, Harmanci O, Gedikoğlu G, et al. Unilobar tapering cirrhosis in a patient with Caroli syndrome associated with an abnormal common bile duct. Turk J Gastroenterol. 2010;21(1):63-67.

A18. Sokmensuer C, Onal IK, Yeniova O, et al. What are the clinical implications of nodular gastritis? Clues from histopathology. Dig Dis Sci. 2009;54(10):2150-2154.

A19. Ersoy O, Harmanci O, Aydinli M, Sivri B, Bayraktar Y. Capability of capsule endoscopy in detecting small bowel ulcers. Dig Dis Sci. 2009;54(1):136-141.

A20. Seren S, Mutchnick M, Hutchinson D, Harmanci O, Bayraktar Y, Mutchnick S, Sahin K, Kucuk O. Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma. Nutr Cancer. 2008;60(6):729-735.

A21. Onal IK, Ersoy O, Aydinli M, Yonem O, Harmanci O, Sokmensuer C, Bayraktar Y. Hepatic granuloma in Turkish adults: a report of 13 cases. Eur J Intern Med. 2008;19(7):527-530.

A22. Harmanci O, Bayraktar Y. Gaucher disease: new developments in treatment and etiology. World J Gastroenterol. 2008;14(25):3968-3973.

A23. Ergen FB, Akata D, Hayran M, Harmanci O, Arslan S, Basaran C, Hussain HK. Magnetic resonance colonography for the evaluation of colonic inflammatory bowel disease: correlation with conventional colonoscopy. J Comput Assist Tomogr. 2008;32(6):848-854.

A24. Bayraktar Y, Harmanci O, Ersoy O, Aydinli M, Balkanci F. "Portal double ductopathy sign" in patients with portal vein cavernous transformation. Hepatogastroenterology. 2008;55(85):1193-1200.

A25. Bayraktar Y, Harmanci O, Büyükasik Y, et al. JAK2V617F mutation in patients with portal vein thrombosis. Dig Dis Sci. 2008;53(10):2778-2783.

A26. Aydinli M, Onal IK, Harmanci O, et al. A case of patent ductus venosus complicated with tumor-like lesions of the liver. J Natl Med Assoc. 2008;100(1):108-111.

A27. Aksoy DY, Ağbaht K, Harmanci O, et al. Autoimmune polyendocrine syndrome with atrial septal defect. Am J Med Sci. 2008;335(2):157-159.

A28. Kurt M, Aksoy S, Cizginer S, Harmanci O, Altundag K, Karaman N. Gastric cancer and the coincidental finding of herpetic esophagitis immediately after pregnancy: a case report. J Reprod Med. 2007;52(5):425-427.

A29. Harmanci O, Onal IK, Ersoy O, et al. Postinfantile giant cell hepatitis due to hepatitis E virus along with the presence of autoantibodies. Dig Dis Sci. 2007;52(12):3521-3523.

30. Harmanci O, Ersoy O, Gurgey A, et al. The etiologic distribution of thrombophilic factors in chronic Aportal vein thrombosis. J Clin Gastroenterol. 2007;41(5):521-527.

A31. Harmanci O, Bayraktar Y. Clinical characteristics of idiopathic portal hypertension. World J Gastroenterol. 2007;13(13):1906-1911.

A32. Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol. 2007;13(18):2535-2540.

A33. Yönem O, Ozkayar N, Balkanci F, et al. Is congenital hepatic fibrosis a pure liver disease? Am J Gastroenterol. 2006;101(6):1253-1259.

A34. Harmanci O, Buyukasik Y, Kirazli S, Balkanci F, Bayraktar Y. Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis? World J Gastroenterol. 2006;12(8):1273-1277.

A35. Harmanci O, Buyukasik Y, Bayraktar Y. Successful plasma exchange treatment in hemolytic crisis of Wilson's disease preventing liver transplantation. Dig Dis Sci. 2006;51(7):1230.

A36. Ersoy O, Aran R, Aydinli M, Yonem O, Harmanci O, Akdogan B, Pinar A, Sokmensuer C, Bayraktar Y.. Granulomatous hepatitis after intravesical BCG treatment for bladder cancer. Indian J Gastroenterol. 2006;25(5):258-259.

A37. Bayraktar Y, Harmanci O. Etiology and consequences of thrombosis in abdominal vessels. World J Gastroenterol. 2006;12(8):1165-1174.

A38. Aydinli M, Harmanci O, Ersoy O, et al. Two unusual cases with Wilson's disease: hepatoma and fulminant hepatitis treated with plasma exchange. J Natl Med Assoc. 2006;98(12):1989-1991.

A39. Kurt M, Harmanci O, Dizdar O, Onal IK, Bayraktar Y. Prolonged anti-HAV IgM positivity in a pregnant woman. Indian J Gastroenterol. 2005;24(4):181-182.

A40. Harmanci A, Harmanci O, Akova M. Hospital-acquired pneumonia: challenges and options for diagnosis and treatment. J Hosp Infect. 2002;51(3):160-167.